Feb 14, 2024

Alumni Council Nominates Three to Join Colby’s Board of Trustees

WATERVILLE, MAINE – NOVEMBER 8: Images of Miller Library’s tower at sunrise, as seen from Outer Main Street in Waterville on Tuesday, November 8, 2022. (Photo by Gabe Souza.)

The Alumni Council is pleased to announce the nomination of three distinguished alumni to serve on the Colby Board of Trustees: Reagan Carey ’01, Jen Millard ’90 P’20, and Jeremy Springhorn ’84 P’19, ’22.


Reagan Carey ’01 serves as Special Advisor to the Professional Women’s Hockey League (PWHL) Board of Directors. With over 20 years of experience working in the sports industry, Carey was an instrumental driver in unifying the world of professional women’s ice hockey that led to the historical launch of the PWHL. Previously Carey served as Commissioner of the Premier Hockey Federation (PHF), delivering the PHF’s mission to provide leading opportunities in professional women’s hockey and growing the sport for its athletes, partners, and fans. Prior to the PHF, Reagan was the Director of Women’s Ice Hockey at USA Hockey and General Manager of the U.S. National Women’s Team from 2010–18, a period of tremendous success during which the USWNT won five U18 titles, five World Championship wins, and Olympic gold in 2018. Reagan competed as a two-sport athlete at Colby, captaining both the ice hockey and volleyball teams. She was the recipient of the Carl E. Nelson Sports Achievement Award in 2010 and was inducted into the Maine Sports Hall of Fame in 2018.


Jen Millard ’90 P’20 is Managing Director and Digital and Technology Consulting Practice Lead for Manatt, Phelps & Phillips, LLP. She has over 25 years of experience in retail operations, strategy, and business development helping enterprises and startups in the fintech and commerce tech sectors achieve their growth potential. Prior to joining Manatt, Millard founded Sanctum Insights, a boutique strategy consulting firm serving some of the world’s most recognized technology, retail, and financial services brands. She has held interim CEO and CRO positions at several tech companies, accelerating revenue, optimizing value, and leading multiple exits, acquisitions, and partnerships. She also completed courses in Innovation for Large Organizations at Stanford University’s d.school Innovation Program, Innovation and Entrepreneurship, and attended the Wisconsin School of Business. Millard is an active Colby volunteer, having served on the Alumni Council as Chair of the Davis Connects Committee in addition to her Class Gift and Reunion Committees and most recently with the Halloran Center for Entrepreneurship. Millard has two children, Matthew and Megan ’20.


Jeremy Springhorn ’84 P’19, ’22 is Chief Executive Officer at Nido Biosciences, which seeks to develop therapies for rare neurological disorders. Springhorn has decades of experience leading scientific, business development, and corporate strategy organizations, including at Syros Pharmaceuticals and Flagship Pioneering. Previously he spent more than 20 years at Alexion Pharmaceuticals, where he served in leadership roles in R&D before switching to business development and was one of the original inventors of the drug Soliris®. Springhorn has served on the corporate or advisory boards of uniQure, N.V., NMD Pharma, and Mythic Therapeutics. He holds a PhD in biochemistry and molecular biology from the LSU Health Sciences Center New Orleans. Springhorn has served on Colby’s Board of Visitors since 2017 and on the Parents Executive Committee while his two children, Hannah ’19 and Ethan ’22, attended Colby.


These nominees were selected from a competitive pool of candidates after an extensive search process. Other nominations may be made by submitting a petition featuring the signatures of one percent of the members of the alumni association to the executive secretary of the Alumni Council at [email protected]. If no petitions are received within 15 days of this announcement, the Alumni Council chair will declare the above nominees to be elected.


This story was posted Feb 17, 2024.